Recently, Siemens Healthcare unveiled its new brand name Siemens Healthineers. The new brand underlines Siemens Healthcare's pioneering spirit and its engineering expertise in the healthcare industry. It is unique and bold and gives a new identity to the Healthcare organization and to its people – the people accompanying, serving and inspiring customers – the people behind outstanding products and solutions.

In addition,, Siemens had bought NEO New Oncology AG one month ago. The company’s main business is development and sales of molecular abnormalities diagnosis platform NEO, it provides the decision support for the doctor’s choice of targeted therapy for cancer patients. Base on this，the Siemens Healthineers for tumor molecular diagnostics markets can be more rapid growth.

As a part of its strategic vision in 2020, Siemens Healthineers will continue to strengthen the leading combination of medical imaging and laboratory diagnostic service, and in the growing market to increase new products, such as management service, consulting and digital services, and advanced technology for treatment and molecular diagnostics.